Ambev (ABEV) files analytical voting map for 2026 general shareholders’ meetings

Rhea-AI Filing Summary

Ambev S.A. filed a Form 6-K to share the final analytical consolidated voting map from its Ordinary and Extraordinary General Shareholders’ Meetings held on April 30, 2026. The document compiles how shareholders voted on each agenda item, including the analysis and approval of managers’ accounts and the financial statements for the fiscal year ended December 31, 2025. The filing is signed by the company’s Chief Financial and Investor Relations Officer, Guilherme Fleury de Figueiredo Ferraz Parolari.

Key Terms

Analytical Consolidated Voting Map, Ordinary and Extraordinary General Shareholders’ Meetings, CVM Ruling No. 81/22, financial statements for the fiscal year ended on December 31, 2025, +1 more

5 terms

Analytical Consolidated Voting Map financial

"publishes the final analytical voting map regarding the consolidation of voting instructions"

Ordinary and Extraordinary General Shareholders’ Meetings financial

"Ordinary and Extraordinary Shareholders’ Meetings of Ambev S.A. held on April 30, 2026"

CVM Ruling No. 81/22 regulatory

"pursuant to article 48, paragraph 6, item II, of CVM Ruling No. 81/22"

financial statements for the fiscal year ended on December 31, 2025 financial

"vote the financial statements for the fiscal year ended on December 31, 2025"

Foreign Private Issuer regulatory

"Report of Foreign Private Issuer Pursuant to Rule 13a-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

Form 6-K: How Foreign Companies Report to the SEC →

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of May, 2026

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 

Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. 

Yes _______ No ___X____

AMBEV S.A. CNPJ [National Register of Legal Entities] No. 07.526.557/0001-00 NIRE [Corporate Registration Identification Number] 35.300.368.941 A Publicly-Held Company ORDINARY AND EXTRAORDINARY GENERAL SHAREHOLDERS’ MEETINGS Analytical Consolidated Voting Map Ambev S.A., pursuant to article 48, paragraph 6, item II, of CVM Ruling No. 81/22, publishes the final analytical voting map regarding the consolidation of voting instructions remotely delivered and the votes delivered in person at the Ordinary and Extraordinary Shareholders’ Meetings of Ambev S.A. held on April 30, 2026, for each matter included on the relevant agenda. Information on the analytical consolidated voting map is provided on the tables below. São Paulo, May 8, 2026. Ambev S.A. Guilherme Fleury de Figueiredo Ferraz Parolari Chief Financial and Investor Relations Office Analytical Consolidated Voting Map Ordinary and Extraordinary General Shareholders’ Meetings – April 30, 2026 Ordinary General Meeting 1. Analyze and approve the managers’ accounts and examine discuss and vote the financial statements for the fiscal year ended on December 31, 2025.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 11, 2026

	AMBEV S.A.
	By:	/s/ Guilherme Fleury de Figueiredo Ferraz Parolari
		Guilherme Fleury de Figueiredo Ferraz Parolari Chief Financial and Investor Relations Officer

FAQ

What does Ambev (ABEV) disclose in this Form 6-K?

Ambev discloses the final analytical consolidated voting map from its Ordinary and Extraordinary General Shareholders’ Meetings held on April 30, 2026. It details how shareholders voted on each agenda item, including managers’ accounts and the 2025 financial statements.

Which shareholders’ meetings are covered for Ambev (ABEV)?

The filing covers Ambev’s Ordinary and Extraordinary General Shareholders’ Meetings held on April 30, 2026. It consolidates both remote and in-person voting instructions for each proposal presented to shareholders at those meetings in São Paulo, Brazil.

What key agenda item is mentioned for Ambev (ABEV)?

One key agenda item was to analyze and approve the managers’ accounts and to examine, discuss, and vote on the financial statements for the fiscal year ended December 31, 2025. The voting map shows how shareholders instructed their votes on this matter.

Why is Ambev (ABEV) publishing an analytical consolidated voting map?

Ambev publishes the analytical consolidated voting map to comply with article 48, paragraph 6, item II, of CVM Ruling No. 81/22. This rule requires disclosure of consolidated voting instructions from remote ballots and in-person votes for each agenda item.

Who signs the Ambev (ABEV) Form 6-K related to the voting map?

The Form 6-K is signed by Guilherme Fleury de Figueiredo Ferraz Parolari, Ambev’s Chief Financial and Investor Relations Officer. His signature confirms the company has duly authorized the report under the requirements of the Securities Exchange Act of 1934.

What period do the Ambev (ABEV) financial statements relate to?

The financial statements referenced in the agenda item relate to the fiscal year ended December 31, 2025. Shareholders were asked to analyze managers’ accounts and then examine, discuss, and vote on those year-end 2025 financial statements at the April 30, 2026 meetings.